Published in J Endocrinol on October 01, 2007
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S A (2015) 1.85
Serotonin and blood pressure regulation. Pharmacol Rev (2012) 1.41
Detection of gene orthology from gene co-expression and protein interaction networks. BMC Bioinformatics (2010) 1.32
Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur J Endocrinol (2011) 1.02
Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology (2010) 0.99
Comparison of aldosterone production among human adrenocortical cell lines. Horm Metab Res (2012) 0.96
Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J Clin Endocrinol Metab (2013) 0.95
DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion. Hypertension (2015) 0.95
Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res (2010) 0.89
G protein-coupled receptor expression in the adult and fetal adrenal glands. Mol Cell Endocrinol (2008) 0.88
Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA). Mol Cell Endocrinol (2014) 0.88
Potassium channels related to primary aldosteronism: Expression similarities and differences between human and rat adrenals. Mol Cell Endocrinol (2015) 0.87
Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2). Endocrinology (2011) 0.84
Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL). Endocrinology (2011) 0.83
Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome. J Clin Endocrinol Metab (2010) 0.83
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol Cell Endocrinol (2014) 0.83
PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J Mol Endocrinol (2014) 0.82
Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma. J Hum Hypertens (2010) 0.79
Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production. Endocrinology (2015) 0.78
Gonadotropin-Releasing Hormone Stimulate Aldosterone Production in a Subset of Aldosterone-Producing Adenoma. Medicine (Baltimore) (2016) 0.78
Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas. Mol Cell Endocrinol (2014) 0.78
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism. Front Endocrinol (Lausanne) (2016) 0.76
Estrogen biosynthesis in human H295 adrenocortical carcinoma cells. Mol Cell Endocrinol (2008) 0.76
Vitamin D receptor, an important transcription factor associated with aldosterone-producing adenoma. PLoS One (2013) 0.75
A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism. J Hum Hypertens (2013) 0.75
Aldosterone-producing adenomas: mining for genes. Hypertension (2010) 0.75
Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues. Hypertension (2016) 0.75
Role of ACTH in the Interactive/Paracrine Regulation of Adrenal Steroid Secretion in Physiological and Pathophysiological Conditions. Front Endocrinol (Lausanne) (2016) 0.75
Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med (2007) 6.58
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev (2002) 3.13
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet (2013) 2.83
Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med (2012) 2.82
Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens (2006) 2.61
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension (2013) 2.25
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens (2006) 2.09
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab (2011) 1.86
Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab (2010) 1.77
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J (2011) 1.67
Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension (2009) 1.57
Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol (2011) 1.55
18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. J Clin Endocrinol Metab (2011) 1.54
Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens (2003) 1.52
Telomerase immortalization of human myometrial cells. Biol Reprod (2002) 1.48
The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J Surg (2008) 1.47
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens (2010) 1.46
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension (2009) 1.45
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer (2005) 1.39
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol (2003) 1.38
Human myometrial gene expression before and during parturition. Biol Reprod (2004) 1.36
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab (2005) 1.32
Transcription elongation factors DSIF and NELF: promoter-proximal pausing and beyond. Biochim Biophys Acta (2012) 1.31
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf) (2004) 1.29
The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase. implications for the control of adrenal functional zonation. J Biol Chem (2004) 1.27
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab (2012) 1.25
Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens (2002) 1.24
A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab (2004) 1.22
The regulation of aldosterone synthase expression. Mol Cell Endocrinol (2004) 1.22
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) (2004) 1.21
The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol (2003) 1.21
Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clin Endocrinol (Oxf) (2007) 1.20
The rise in adrenal androgen biosynthesis: adrenarche. Semin Reprod Med (2004) 1.20
Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab (2005) 1.19
Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? Surgery (2007) 1.17
Ovarian granulosa cell lines. Mol Cell Endocrinol (2004) 1.17
Adrenarche - physiology, biochemistry and human disease. Clin Endocrinol (Oxf) (2004) 1.16
Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology (2002) 1.16
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clin Chem Lab Med (2010) 1.15
Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells. J Mol Endocrinol (2007) 1.13
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
Human adrenocortical carcinoma cell lines. Mol Cell Endocrinol (2011) 1.12
Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab (2002) 1.11
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens (2007) 1.10
Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line. J Clin Endocrinol Metab (2008) 1.09
Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol (2009) 1.09
Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata. Endocrinology (2012) 1.08
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab (2013) 1.05
GATA-6 is expressed in the human adrenal and regulates transcription of genes required for adrenal androgen biosynthesis. Endocrinology (2003) 1.05
Profiling transcript levels for steroidogenic enzymes in fetal tissues. J Steroid Biochem Mol Biol (2003) 1.04
A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res (2004) 1.03
Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. J Clin Endocrinol Metab (2005) 1.03
Ubc9 and Protein Inhibitor of Activated STAT 1 Activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated Human CYP11B2 Gene Transcription. J Biol Chem (2004) 1.03
Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur J Endocrinol (2011) 1.02
Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression. Am J Physiol Heart Circ Physiol (2011) 1.02
Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Hypertension (2011) 1.02
Adrenal changes associated with adrenarche. Rev Endocr Metab Disord (2009) 1.02
Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab (2006) 1.02
FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins. Endocr Res (2004) 1.00
Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Cancer Sci (2009) 1.00
Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor alpha. Endocrinology (2005) 1.00
ACTH is a potent regulator of gene expression in human adrenal cells. J Mol Endocrinol (2010) 0.99
Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology (2010) 0.99
Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology (2008) 0.99
The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression. Hum Reprod (2005) 0.98
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype. PLoS Genet (2013) 0.98
The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol (Oxf) (2009) 0.98
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. J Clin Endocrinol Metab (2014) 0.97
Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens (2004) 0.97
Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin Endocrinol (Oxf) (2010) 0.97
Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol (Oxf) (2008) 0.97
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens (2007) 0.96
The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. Am J Surg Pathol (2013) 0.96
Angiotensin II regulation of adrenocortical gene transcription. Mol Cell Endocrinol (2008) 0.96
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. Thyroid (2011) 0.96
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod (2009) 0.96
Role of nitric oxide concentrations on human sperm motility. J Androl (2004) 0.95
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol (2011) 0.95
Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. J Clin Endocrinol Metab (2013) 0.95
Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome. FASEB J (2011) 0.95
Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. J Biol Chem (2006) 0.95
Corticotropin-releasing hormone directly stimulates cortisol and the cortisol biosynthetic pathway in human fetal adrenal cells. J Clin Endocrinol Metab (2004) 0.95
Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab (2009) 0.95
Liver receptor homolog-1 regulates the expression of steroidogenic acute regulatory protein in human granulosa cells. J Clin Endocrinol Metab (2004) 0.94
Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil Steril (2004) 0.94
Peroxisome proliferator-activated receptor-{gamma} suppresses CYP11B2 expression and aldosterone production. J Mol Endocrinol (2011) 0.94